Humans’ Big Brains Might Be Due in Part to Newly Identified Protein
A protein that may partly explain why human brains are larger than those of other animals has been identified by scientists from two stem-cell labs at UCSF.
University of California San Francisco
Give to UCSFA protein that may partly explain why human brains are larger than those of other animals has been identified by scientists from two stem-cell labs at UCSF.
UCSF neuroscientist Roger Nicoll, MD, has received the Society for Neuroscience’s (SfN) highest award, the Ralph W. Gerard Prize in Neuroscience. He and Richard W. Tsien, DPhil, of New York University, will share the $25,000 prize.
Two major genetic studies of autism, led in part by UCSF scientists and involving more than 50 laboratories worldwide, have newly implicated dozens of genes in the disorder.
New motor learning research suggests that "muscle memory" is actually something the brain is constantly relearning.
A team of UCSF researchers has found that a tiny segment of genetic material known as a microRNA plays a central role in the transition from moderate drinking to alcohol use disorders.
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
Adam Boxer, MD, PhD, and Howie Rosen, MD, of the Memory and Aging Center (MAC), have won a $6.25 million grant to study Frontotemporal Lobar Degeneration (FTLD) through the Rare Diseases Clinical Research Network (RDCRN), which is led by National Institute’s of Health’s National Center for Advancing Translational Sciences (NCATS).
Video games that make you smarter. A chip that can identify mysterious illnesses in hours. These are some of the topics top UCSF scientists will discuss at this year’s free UCSF Dreamforce track on Oct. 15.
Five UCSF neuroscientists have received research grants in the highly competitive first wave of National Institutes of Health (NIH) awards to support President Obama’s BRAIN Initiative.
UCSF researchers have used brain scans to predict how young children learn to read, giving clinicians a possible tool to spot children with dyslexia and other reading difficulties before they experience reading challenges.
A new study suggests that colds and other minor infections may temporarily increase stroke risk in children.
UCSF researchers have identified cells’ unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that large-scale cell surveys can be done much more efficiently and cheaply than was previously thought possible.
Researchers at UCSF have found that children with sensory processing disorders have decreased structural brain connections in specific sensory regions different than those in autism, further establishing SPD as a clinically important neurodevelopmental disorder.
Researchers at UCSF have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
A brain region that is vital for memory and shrinks in Alzheimer’s disease patients also is likely to be smaller in those whose white blood cells have shorter DNA-protecting end caps – called telomeres – according to a study by Stanford and UCSF researchers.
A team led by UCSF scientists has identified eight drugs that may stimulate nervous system repair in multiple sclerosis (MS).
UCSF researchers have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.
In a new study by UC San Francisco scientists, running, when accompanied by visual stimuli, restored brain function to normal levels in mice that had been deprived of visual experience in early life.
UC San Francisco and the University of Nebraska Medical Center have been awarded a $10 million grant from the Centers for Medicare & Medicaid Innovation to create a new web-based model of dementia care.
Parents who have a child with autism spectrum disorder (ASD) are about one third less likely to have more children than families without an affected child, according to a study led by a UC San Francisco researcher.
The Brain Health Registry – led by top researchers at UC San Francisco – is a new, groundbreaking, web-based project designed to speed up cures for Alzheimer’s, Parkinson’s and other brain disorders.
UCSF won gold and silver medals in an international contest from the Council for Advancement and Support of Education (CASE), which announced its Circle of Excellence awards Wednesday morning.
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
Scientists and physicians at UCSF are leading a $26 million, multi-institutional research program to better understand and treat a range of common, debilitating psychiatric disorders.
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
As players from a wide range of industries continue to venture into health and health care, it will be imperative for UCSF to form new partnerships to address familiar health challenges in creative, novel ways.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as “astrocytes,” because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UCSF researchers.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.